Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG. Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med. 2007;35(4):1099–104. doi:10.1097/01.CCM.0000259462.97164.A0.
Article
PubMed
Google Scholar
Horvatits T, Trauner M, Fuhrmann V. Hypoxic liver injury and cholestasis in critically ill patients. Curr Opin Crit Care. 2013;19(2):128–32. doi:10.1097/MCC.0b013e32835ec9e6.
Article
PubMed
Google Scholar
Jager B, Drolz A, Michl B, Schellongowski P, Bojic A, Nikfardjam M, et al. Jaundice increases the rate of complications and 1-year mortality in patients with hypoxic hepatitis. Hepatology. 2012;56(6):2297–304. doi:10.1002/hep.25896.
Article
PubMed
Google Scholar
Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003;82(6):392–406. doi:10.1097/01.md.0000101573.54295.bd.
Article
PubMed
Google Scholar
Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37(8):1302–10. doi:10.1007/s00134-011-2248-7.
Article
PubMed
Google Scholar
Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369(26):2525–34. doi:10.1056/NEJMra1208937.
Article
CAS
PubMed
Google Scholar
Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, et al. Acute-on chronic liver failure. J Hepatol. 2012;57(6):1336–48. doi:10.1016/j.jhep.2012.06.026.
Article
PubMed
Google Scholar
Henrion J, Minette P, Colin L, Schapira M, Delannoy A, Heller FR. Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology. 1999;29(2):427–33. doi:10.1002/hep.510290202.
Article
CAS
PubMed
Google Scholar
Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 2009;35(8):1397–405. doi:10.1007/s00134-009-1508-2.
Article
PubMed
Google Scholar
Drolz A, Horvatits T, Michl B, Roedl K, Schellongowski P, Holzinger U, et al. Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients. J Hepatol. 2014;60(6):1187–93. doi:10.1016/j.jhep.2014.01.019.
Article
CAS
PubMed
Google Scholar
Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960;39:592–600. doi:10.1172/JCI104072.
Article
PubMed Central
CAS
PubMed
Google Scholar
Vos JJ, Wietasch JK, Absalom AR, Hendriks HG, Scheeren TW. Green light for liver function monitoring using indocyanine green? An overview of current clinical applications. Anaesthesia. 2014;69(12):1364–76. doi:10.1111/anae.12755.
Article
CAS
PubMed
Google Scholar
Yokoyama Y, Nishio H, Ebata T, Igami T, Sugawara G, Nagino M. Value of indocyanine green clearance of the future liver remnant in predicting outcome after resection for biliary cancer. Br J Surg. 2010;97(8):1260–8. doi:10.1002/bjs.7084.
Article
CAS
PubMed
Google Scholar
Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl. 2004;10(2 Suppl 1):S39–45. doi:10.1002/lt.20040.
Article
PubMed
Google Scholar
Jochum C, Beste M, Penndorf V, Farahani MS, Testa G, Nadalin S, et al. Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl. 2006;12(4):544–9. doi:10.1002/lt.20627.
Article
PubMed
Google Scholar
Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, Seufferlein T, et al. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Gut. 2010;59(7):963–8. doi:10.1136/gut.2010.208595.
Article
PubMed
Google Scholar
Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, et al. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Liver Int. 2009;29(10):1516–20. doi:10.1111/j.1478-3231.2009.02104.x.
Article
CAS
PubMed
Google Scholar
Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M, Cecinato P, Turco L, et al. Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology. 2014;59(2):643–50. doi:10.1002/hep.26700.
Article
CAS
PubMed
Google Scholar
Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest. 2002;122(5):1715–20.
Article
PubMed
Google Scholar
Zoller B, Spanaus K, Gerster R, Fasshauer M, Stehberger PA, Klinzing S, et al. ICG-liver test versus new biomarkers as prognostic markers for prolonged length of stay in critically ill patients—a prospective study of accuracy for prediction of length of stay in the ICU. Ann Intensive Care. 2014;4:19. doi:10.1186/s13613-014-0019-7.
Article
PubMed Central
PubMed
Google Scholar
Kortgen A, Paxian M, Werth M, Recknagel P, Rauchfuss F, Lupp A, et al. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock. 2009;32(4):358–65. doi:10.1097/SHK.0b013e31819d8204.
Article
PubMed
Google Scholar
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.
Article
CAS
PubMed
Google Scholar
Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–63.
Article
PubMed
Google Scholar
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464–70. doi:10.1053/jhep.2001.22172.
Article
CAS
PubMed
Google Scholar
Mutschler M, Nienaber U, Munzberg M, Wolfl C, Schoechl H, Paffrath T, et al. The Shock Index revisited—a fast guide to transfusion requirement? A retrospective analysis on 21,853 patients derived from the TraumaRegister DGU. Crit Care. 2013;17(4):R172. doi:10.1186/cc12851.
Article
PubMed Central
PubMed
Google Scholar
Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35(11):2498–508. doi:10.1097/01.CCM.0000287592.94554.5F.
Article
PubMed
Google Scholar
Sakka SG, Koeck H, Meier-Hellmann A. Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med. 2004;30(3):506–9. doi:10.1007/s00134-003-2091-6.
Article
PubMed
Google Scholar
Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med. 2000;26(10):1553–6.
Article
CAS
PubMed
Google Scholar
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228. doi:10.1007/s00134-012-2769-8.
Article
CAS
PubMed
Google Scholar
Werdan K, Russ M, Buerke M, Delle-Karth G, Geppert A, Schondube FA. Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment: a German-Austrian S3 Guideline. Dtsch Arztebl Int. 2012;109(19):343–51. doi:10.3238/arztebl.2012.0343.
PubMed Central
PubMed
Google Scholar
Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856–64, 864 e851. doi:10.1053/j.gastro.2009.06.006.
Jara M, Malinowski M, Luttgert K, Schott E, Neuhaus P, Stockmann M. Prognostic value of enzymatic liver function for the estimation of short-term survival of liver transplant candidates: a prospective study with the LiMAx test. Transpl Int. 2015;28(1):52–8. doi:10.1111/tri.12441.
Article
PubMed
Google Scholar
Kaffarnik MF, Lock JF, Vetter H, Ahmadi N, Lojewski C, Malinowski M, et al. Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test. Crit Care. 2013;17(5):R259. doi:10.1186/cc13089.
Article
PubMed Central
PubMed
Google Scholar
Sakka SG, Hofmann D, Thuemer O, Schelenz C, van Hout N. Increasing cardiac output by epinephrine after cardiac surgery: effects on indocyanine green plasma disappearance rate and splanchnic microcirculation. J Cardiothorac Vasc Anesth. 2007;21(3):351–6. doi:10.1053/j.jvca.2006.02.031.
Article
CAS
PubMed
Google Scholar